Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management Chen J; Dassarath M; Yin Z; Liu H; Yang K; Wu GRadiat Oncol 2011[Sep]; 6 (ä): 128Temporal lobe necrosis (TLN) is the most debilitating late-stage complication after radiation therapy in patients with nasopharyngeal cancer (NPC). The bilateral temporal lobes are inevitably encompassed in the radiation field and are thus prone to radiation induced necrosis. The wide use of 3D conformal and intensity-modulated radiation therapy (IMRT) in the treatment of NPC has led to a dwindling incidence of TLN. Yet, it still holds great significance due to its incapacitating feature and the difficulties faced clinically and radiologically in distinguishing it from a malignancy. In this review, we highlight the evolution of different imaging modalities and therapeutic options. FDG PET, SPECT and Magnetic Spectroscopy are among the latest imaging tools that have been considered. In terms of treatment, Bevacizumab remains the latest promising breakthrough due to its ability to reverse the pathogenesis unlike conventional treatment options including large doses of steroids, anticoagulants, vitamins, hyperbaric oxygen and surgery.|*Necrosis[MESH]|Antibodies, Monoclonal, Humanized/therapeutic use[MESH]|Anticoagulants/therapeutic use[MESH]|Bevacizumab[MESH]|Humans[MESH]|Magnetic Resonance Spectroscopy/methods[MESH]|Nasopharyngeal Neoplasms/complications/*radiotherapy[MESH]|Oxygen/chemistry[MESH]|Positron-Emission Tomography/methods[MESH]|Radiation Injuries/*diagnosis/therapy[MESH]|Radiotherapy/*adverse effects[MESH]|Steroids/therapeutic use[MESH]|Temporal Lobe/*pathology/*radiation effects[MESH]|Tomography, Emission-Computed, Single-Photon/methods[MESH]|Treatment Outcome[MESH]|Vitamins/metabolism[MESH] |